INTRODUCTION
Microbiome refers to the genetic potential of the entire cohort of resident microorganisms (commensal, symbiotic, and pathogenic) that inhabit a given niche and function as an organized community [1] . Although the exact role of the microbiome and its relation to chronic disease processes remains largely unknown, we now understand that the disruption of indigenous microbiota (dysbiosis) may lead to pathogen overgrowth and increased susceptibility to infection. This has previously been demonstrated in the gastrointestinal tract and lower airways [2] [3] [4] , but has not been as thoroughly investigated in the upper airway.
The purpose of this article was to review current literature regarding the microbiome of the upper airway by subsite and its relation to chronic inflammatory disease processes. In particular, we focused on four specific subsites: the nasal cavity, paranasal sinus cavities, nasopharynx, and larynx, with the goal to identify common microbiome alterations or disease mechanisms in patients with chronic disorders at these subsites. Specifically, we examined chronic rhinitis, chronic sinusitis, chronic otitis media, and reflux laryngitis, respectively.
METHODS
A systematic literature search was performed using the Medline, EMBASE, and Cochrane Review databases up to October 1, 2018, on recent studies that investigated the upper airway microbiome. Keywords used in the initial screening included ''microbiome,'' ''microbe,'' ''microbial,'' and ''community.'' A secondary search was also completed for specific classes of microbes by using the following keywords: ''bacteria'' and ''bacterial.'' Finally, a tertiary search was conducted using keywords: ''nasal cavity,'' ''chronic rhinitis,'' ''sinus,'' ''chronic sinusitis,'' ''nasopharynx,'' ''otitis media,'' ''larynx,'' and ''reflux laryngitis.'' References of original articles and relevant reviews were individually retrieved and perused for pertinent findings to identify those studies that specifically assessed the upper airway microbiome in healthy and unhealthy patients. In particular, we attempted to identify those articles specifically examining the role of microbiota in four upper airway sites (nasal cavity, sinus cavities, nasopharynx, and larynx) and connect these microbiota profiles to disease processes. Specifically, we sought to link dysbioses of these anatomic sites to corresponding diseases of interest: chronic rhinitis, chronic sinusitis, chronic otitis media, and reflux laryngitis, respectively.
NASAL CAVITY
Chronic rhinitis affects up to 20% of the population globally and consists of a heterogeneous group of suspected etiologies that results in chronic inflammation [5, 6] . It can broadly be classified into allergic rhinitis, infectious rhinitis, and nonallergic rhinitis. We sought to examine the role of dysbiosis of the nasal microbiome in each of these disease entities.
Hyun et al. [7 && ] recently performed a prospective study to characterize the microbiota of the inferior turbinate via biopsies in 20 allergic rhinitis patients and 20 healthy controls undergoing septoplasty. In addition, they also sought to investigate the relationship of mucosal microbiota with presence of disease, allergen number, as well as allergen-specific and total immunoglobulin E (IgE) levels. The results showed that alterations toward dysbiosis in the composition and predicted function of the inferior turbinate microbiota in individuals with allergic rhinitis were associated with high total IgE levels. Furthermore, the dominance of Staphylococcus in the altered microbiota suggested the importance of its role in allergic rhinitis development and progression. An increase in both Staphylococcus and a decrease in the phylum Actinobacteria were linked to high total IgE levels in allergic rhinitis. Thus, the authors concluded that the inferior turbinate microbiota may be impacted by collective allergic responses against sensitized allergens, and that site-specific microbial changes may contribute to disease pathophysiology.
Ramakrishnan et al. [8 & ] performed a prospective longitudinal study to examine the shift of microbiota in response to physician-prescribed interventions. In this study, five study participants were serially examined over an 8-week period using pan-bacterial 16S rRNA gene sequencing. Four of these patients were administrated topical mometasone furoate spray, whereas one study participant underwent a mupirocin decolonization procedure in anticipation of orthopedic surgery. The results showed that microbial diversity was unaffected by intranasal treatment in two patients but markedly increased in the remaining three. This was secondary to clearance of Moraxella and a simultaneous increased in members of the phylum Actinobacteria. Both of these effects persisted at least 2 weeks beyond cessation of treatment. Furthermore, there were transient changes in the relative abundance of several bacterial genera, including Staphylococcus and Propionibacteria (Actinobacteria phylum).
In both of these articles, two key generaStaphylococcus and Propionibacteria -appear to be implicated in the development of chronic rhinitis.
SINUS
Chronic rhinosinusitis (CRS) represents one of the most common healthcare problems in the United States, with one in seven adults affected and 31 million newly diagnosed individuals each year [9, 10] . No clear cause, however, has been identified. The pathogenesis is likely multifactorial with both host (allergy, immunodeficiency, ciliary immotility, and anatomic obstruction) and environmental factors (bacterial and/or viral infections, biofilms, and pollutants) believed to play a role in its development [11] .
A recent meta-analysis conducted by Mackenzie et al. [12 && ] sought to examine potential differences in sinonasal bacterial community composition and to predict function between healthy and CRS patients. They found that the most abundant bacteria for all study participants were Staphylococcus, Propionibacterium, Corynebacterium, Streptococcus, and an unclassified lineage of Actinobacteria. The results from the meta-analysis suggested that in CRS patients, ecological networks promoting
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Rhinitis, sinusitis and upper airway disease healthy communities become fragmented, leading to dispersion of bacterial communities, reduced bacterial diversity, and increased abundance of Corynebacterium. Furthermore, elevated relative abundance and diversity of members from the phylum Actinobacteria and genus Propionibacterium differentiated healthy sinuses from sinuses were chronically inflamed. The absence of Burkholderia and Propionibacterium phylotypes from the healthy community dataset were associated with increased network fragmentation, leading the authors to conclude that these two genera may act as gatekeepers with their presence playing a critical role in maintaining a stable sinonasal bacterial community.
Similarly, Hoggard et al. [13 & ] sought to differentiate bacterial communities in 94 patients with CRS undergoing endoscopic sinus surgery (ESS) and 29 controls undergoing ESS for indications other than CRS. Bacterial communities underwent 16S rRNA gene amplicon sequencing and quantification with polymerase chain reaction. Control patients were primarily composed of members of the genera Corynebacterium and Staphylococcus, with lower abundance of Streptococcus, Moraxella, and Haemophilus. The dysbiotic communities in CRS patients were mostly composed of members from genera Staphylococcus, Streptococcus Haemophilus, Pseudomonas, Moraxella, or Fusobacterium.
Kuhar et al. [14 & ] also obtained sinus swabs during ESS for CRS patients and assessed the microbiome alterations and potential relationship to tissue histopathology. In 51 patients, they found that a relative abundance of Firmicutes correlated with neutrophilic infiltration, mucosal ulceration, squamous metaplasia, and absence of Charcot-Leyden crystals. Relative abundance of Bacteroidetes phylum was associated with increased inflammation severity and mucosal ulceration. The authors thus concluded that the phyla Firmicutes and Bacteroidetes correspond to distinct pathologic features of CRS.
Koeller et al. [15 & ] compared the microbiome of healthy study participants to that of patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) and chronic rhinosinusitis without nasal polyposis (CRSsNP) during ESS. They found no clear distinction between bacterial communities in healthy versus CRSwNP patients, but found a relative abundance of Flavobacterium, Pseudomonas, Pedobacter, Porphyromonas, Stenotrophomonas, and Brevundimonas in CRSsNP versus healthy controls. These authors thus concluded that changes in the microbiome may be a more critical factor for development of CRSsNP compared to CRSwNP.
In a similar approach, Cope et al. [16] evaluated sinus brushings from CRS and control patients (59 versus 10, respectively), and assessed the microbiome compared to tissue RNA profiling and predictive metagenomics. The authors defined three categories of CRS, termed phylotypes, in which each consisted of functionally distinct microbiomes and host immune responses. Mahdavinia et al. [17] similarly utilized predictive metagenomics to identify dysregulated bacterial functional pathways computationally derived from 16S rRNA gene sequencing of middle meatal swabs from CRS versus control study participants. Although the identified pathways in the two studies were actually different, these are two articles that have implicated functional bacterial pathways in the chronic inflammatory disease process of CRS.
LARYNX
An estimated 18 million Americans report voice problems each year [18] . The vocal folds are composed of stratified squamous epithelium and underlying lamina propia, and they reside in the larynx at the junction between the respiratory and gastrointestinal tracts. In patients with chronic laryngeal inflammation, it is difficult to establish an exact cause, but it has often been attributed to acid reflux, smoking, allergies, vocal overuse, or a combination of these factors [19 && ]. The incomplete understanding we currently have of the pathophysiology of chronic laryngeal inflammation represents a barrier to adequate treatment in most patients. Frequently, patients are empirically treated with proton pump inhibitors, but this has demonstrated limited efficacy [20] .
Only four prior studies published to date have examined the role of laryngeal microbes in disease, including chronic laryngitis, vocal fold polyps, nodules, cysts, laryngeal cancer, and Reinke's edema [19 && ]. None of these studies, however, have compared microbial data of diseased versus healthy tissue.
Jette et al. [19 && ] is the first known study to examine the contribution of the two most commonly known mucosal irritants, cigarette smoke and reflux, to microbial community composition in the larynx. The authors hypothesized that refluxed material from the stomach may lead to colonization of the upper respiratory tract in patients with reflux laryngitis; and therefore microbiota found in laryngeal tissue and the stomach in these patients would be similar. In this study, the authors investigated the laryngeal microbiome of 97 healthy volunteers using 16S rRNA sequencing. Similar to previous studies looking at laryngeal microbiome in healthy study participants, there was highly abundant Cordnarnonadaceae. In smokers, however, they found reduced microbial diversity with differences in relative abundances of Streptococcus, unclassified Cordnarnonadaceae, Cloacibacterium, and Helicobacter. Reflux status, however, did not appear to impact microbial diversity, community structure, or composition. Furthermore, when the authors examined the laryngeal microbiome of healthy patients versus those with benign vocal fold disease, they found an abundance of Streptococcus in the latter group.
The authors thus concluded that the diversity of the laryngeal microbiome is affected by smoking, but not by reflux. The preponderance of Streptococcus in both smokers and those with benign vocal fold lesions versus healthy subjects suggests that this bacteria may contribute to the pathophysiology of laryngeal disease.
NASOPHARYNX
Otitis media is a very common childhood disease. It represents the leading cause of visits to the pediatrician by children, and is also the most frequent indication that children consume antibiotics or undergo surgery [21] [22] [23] . Given its prevalence in the pediatric population, our literature search of the nasopharyngeal microbiota yielded a majority of studies conducted in this population.
In determining the relevance of the microbiota of the nasopharynx, we sought to identify changes in the host microbiota in patients with otitis media. Chonmaitree et al. [24 && ] assessed nasopharyngeal microbiota in infants followed from near birth to the first acute otitis media (AOM) episode or 12 months of age to determine how fluctuations in nasopharyngeal bacterial colonization could potentially lead to viral upper respiratory tract infection (URI) and AOM.
The authors analyzed 971 specimens collected monthly and during URI and AOM episodes from 139 infants to elucidate interactions between nasopharyngeal microbial pathogens and commensals. The data were collected longitudinally during both health and disease. The highly abundant genus-level nasopharyngeal microbiota included Moraxella, nontypeable Haemophilus influenzae, and Streptococcus (three otopathogen genera); Corynebacterium, Dolosigranulum, Staphylococcus, Acinetobacter, Pseudomonas, and Bifidobacterium. The authors thus concluded that the bacterial otopathogen genera Moraxella, Haemophilus influenzae, and Streptococcus played critical roles in development of AOM. The increasing trend in colonization of these otopathogen genera also correlated with frequencies of URI. Furthermore, Staphylococcus, but not the commonly used probiotic bacterium Bifidobacterium, appeared to counteract the deleterious effects of these otopathogens.
Interestingly, the authors found that during symptomatic viral infection, there were significant increases in the relative abundance of otopathogen genera, but no significant change in otopathogen or commensals during asymptomatic viral infection. Stability of the microbiome during asymptomatic viral infection may therefore play a role in the failure of asymptomatic viral infection to progress to AOM.
Lappan et al.
[25 & ] performed a case-controlled study of recurrent AOM (rAOM) to identify potentially protective bacterial genera. They hypothesized that healthy children with no history of AOM harbor protective commensal bacteria that could be used as potential probiotic therapy to inhibit the cycle of reinfection. They compared nasopharyngeal swabs from both children with rAOM and healthy controls using 16S rRNA gene sequencing. In the control group, there was a significantly higher abundance of Corynebacterium and Dolosigranulum. The authors thus concluded that these two genera are characteristic of a healthy nasopharyngeal microbiome. Of note, Alloiococcus, Staphylococcus, and Turicella were abundant in the middle ear and ear canal of the rAOM group but uncommon in the nasopharynx of both groups. The authors believe that these three present possible novel otopathogens could contribute to rAOM.
CONCLUSION
The role of microbiota in the upper airway is incompletely understood, although appears implicated in several disease processes. Healthy adults seem to harbor anatomical site-specific core microbiota that directly influence immunity and epithelial barrier function [8 & ]. When this baseline microbiota at a particular body subsite, however, is subjected to perturbation from external stimuli (e.g., bacterial, virus, pH changes, and medications), this could result in at least a transient shift away from the stable core. This shift may ultimately be responsible for creating periods of increased susceptibility to disease or pathophysiology.
Based on the recent review of literature comparing healthy versus diseased patients with site-specific inflammatory conditions (Table 1) , there are still many unanswered questions regarding the significance of microbiomes. Although we recognize that complex microbial communities are present throughout the upper airway, further investigation is necessary to better understand how fluctuations in the baseline microbiome contribute to disease pathogenesis. Furthermore, a better delineation of the dynamics between shifting microbiota is critical to understanding the microbial contribution to these disease processes, and guiding any potential future medical interventions.
